Delivery Order SPE2DB20D2104-SPE2DB25FMRHQ
Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,864.45 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on September 4, 2025, with completion targeted for September 5, 2025. This non-competitive delivery order represents a firm fixed price transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody...
- The Defense Logistics Agency awarded a delivery order valued at $1,213.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of July 29, 2025. The contract, issued on July 28, 2025, employs firm fixed-price pricing and was awarded through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.00 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $19,429.58 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on September 19, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Emgality is a migraine prevention medication used in military and federal healthcare systems to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emgality 120 mg/mL pen injectors, valued at $1,556.10. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-competitive set-aside award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency (DLA) awarded a $3,457 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitive, firm fixed-price contract was issued without set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The product—Emgality (erenumab)—is a monoclonal antibody used for migraine prevention, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,530.62 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.34 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors. This is a firm fixed price, non-set-aside contract completed on September 4, 2025. The order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, with performance fulfilled at the company's Conshohocken, Pennsylvania location. Emgality is a migraine prevention medication, reflecting the breadth of...
- The Defense Logistics Agency awarded a $2,348.61 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on September 4, 2025, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. Emgality is a calcitonin gene-related peptide monoclonal antibody used in migraine prevention, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $1,401.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen (injectable migraine treatment) with a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the company's Conshohocken, Pennsylvania facility, where...